275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
During the pandemic, we have adapted our Early Phase facilities and processes to mitigate viral transmission risks. Each of our units can support COVID-19 related product development. Flexible capacity models and decentralized clinical trial processes have been introduced where possible because there is no moment to lose in the race to bring the pandemic to a close.
Rapidly progressing through Phase I-II trials to achieve proof of concept is a critical milestone in your strategy. It is also a crucial milestone of hope for patients with unmet needs. At Parexel, we design our early phase clinical trials to bring hope to these groups of patients sooner.
Our 80+ former regulators know first-hand the leading causes of early phase delays from a regulator's perspective. These include inappropriate scientific justification of the dose, misaligned safety thresholds, and study design challenges.
Parexel has the expertise to help mitigate these risks. We can bring together integrated teams of regulatory, pharmacology, and translational medicine experts to inform the doses of the drugs, safety selection, and PK/PD evaluation. We help design a protocol that works harder and smarter for you, generating the data you'll need to inform decision-making.
And when you are ready to begin your Early Phase studies, our global network of early phase clinics provide a full scope of services.
These services include:
Learn how to participate in a clinical trial and discover how you can help greatly improve lives worldwide for decades to come.
"I'm doing something that in a small way benefits the future of modern medicine." -Simon, Volunteer Participant. Learn how you can help us develop impactful therapies for patients around the world.
Simon:
There's lots of illnesses out there that we still don't have cures for. So without trials, we're going nowhere.
Gillian:
My experience participating on the clinical trials that I've been on, it's been really good. I think the staff were just so professional, and warm, and welcoming.
Amanda:
We're all in it as one big team who are looking to further the development of new medicines for those diseases that ultimately improve the quality of life of individuals.
Simon:
I'm doing something in a small way that's beneficial to the future of modern medicine.
Lorenzo:
I've most probably participated in about 30 trials over a 20 year period. The main thing I like about doing clinical trials is you're away from the everyday, and take part in a trial which obviously helps in clinical research.
Benjamin:
You got time to watch films and use the recreation room, and meet new people, as well, which I thought was really good, just to interact with other people from different walks of life.
Abdul:
One of the things that I like working for Parexel is the interactions that I have with the volunteers. I make sure I just make them feel welcome, like home.
Wilma:
I have a very good relationship with the volunteers. We laugh, we joke.
Bartosz:
I usually find out about medical trials by calling in. There's also websites that I've been using quite often to find out if there's anything going on.
Amanda:
So we can also reach out to our volunteers and patients via a Facebook page that we have, and also Instagram. Some of our patients and volunteers prefer to be contacted by text messaging, as well.
Jackie:
When you come into the unit, the staff really welcome you. If you're new, they'll go through everything step by step.
Daniel:
I come to the clinic and see if the volunteers are okay. I'll answer any questions that they might have, also.
Haseeb:
The thing that makes me keep on coming back here, by far, is definitely the staff. They are very friendly, they always make you feel comfortable.
Radomira:
It's really nice to have new people. We tell them what we need from them. They tell us if they have any concerns. We try to bring them on so they're part of the team.
Alexander:
I think it's very important that people participate in clinical trials because it's the origins of medicine.
Suresh:
The healthy volunteers and patients who are participating in the trial are the backbone for the drug development. Their contribution of their time is crucial for the world.
Elaine:
When you think about the amount of things that we haven't even found a cure for, this is just a stepping stone towards that. It has to make a difference, is what I always feel. Even if it's one person, then that's the best thing.
Practically Speaking: Driving Clinical Transformation, Part Two
Watch now
Practically Speaking: Driving Clinical Transformation, Part One
Watch now
FSP 2.0: Why Talent Development is the New Talent Acquisition
Watch now
mHealth Innovation_Identifying the Best Patient-Centered Tech for Clinical Trials
View now
Operationalizing Cell and Gene Therapy Trials
View now
Browse the Parexel Resource Center for our latest content on clinical trial supplies, logistics, innovation, drug safety, cell & gene therapy, and more!
Practically Speaking: Driving Clinical Transformation, Part Two
Watch Now
Practically Speaking: Driving Clinical Transformation, Part One
Watch Now
FSP 2.0: Why Talent Development is the New Talent Acquisition
Watch Now
mHealth Innovation_Identifying the Best Patient-Centered Tech for Clinical Trials
View Now
Operationalizing Cell and Gene Therapy Trials
View Now
Preparing for a Risk-based Future
View Now
The Rise of FSP Outsourcing
View Now
Real-world evidence for more efficient, patient-focused trials
View Now
Innovating for the Future of Drug Development
View Now
Making rare disease drug development personal
View Now
The science of ethnobridging
View Now
Top Ten Rules for Success in DCTs
View Now
Master Protocols from Design to Delivery
View Now
COVID-19 The Great Decentralized Clinical Trials Accelerator
View Now
Landing in the EU – The importance of choosing the right experts for EU/EEA QPPV
View Now
Preparing for Our Risk-based Future: Using Change Management to Drive RBQM Adoption
View Now
Bringing clinical trials to patients with the decentralized model
View Now
Risk-based Quality Management Video (RBQM) Series, Part Three
Watch Now
Risk-based Quality Management (RBQM) Video Series, Part One
Watch Now
Risk-based Quality Management Video (RBQM) Series, Part Two
Watch Now
The Workforce of the Future: Spotlight on Statistical Programmers
Watch Now
Parexel FSP: delivering high-performance, day one
Watch Now
Identifying the right FSP candidates on day one
Watch Now
Parexel FSP: Making a difference from day one
Watch Now
Partnering with clients day one to find better solutions
Watch Now
The FSP Workforce of the Future: Spotlight on CRAs
Watch Now
We are always available for a conversation.